Baxter International (BAX) EBITDA (2016 - 2024)
Historic EBITDA for Baxter International (BAX) over the last 16 years, with Q4 2024 value amounting to $959.0 million.
- Baxter International's EBITDA rose 4845.2% to $959.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $3.2 billion, marking a year-over-year increase of 35403.11%. This contributed to the annual value of $14.0 million for FY2024, which is 9801.98% down from last year.
- As of Q4 2024, Baxter International's EBITDA stood at $959.0 million, which was up 4845.2% from $1.0 billion recorded in Q3 2024.
- Baxter International's EBITDA's 5-year high stood at $1.0 billion during Q3 2024, with a 5-year trough of -$2.9 billion in Q3 2022.
- For the 5-year period, Baxter International's EBITDA averaged around $205.9 million, with its median value being $360.5 million (2020).
- Per our database at Business Quant, Baxter International's EBITDA crashed by 145652.17% in 2022 and then surged by 616470.59% in 2024.
- Quarter analysis of 5 years shows Baxter International's EBITDA stood at $406.0 million in 2020, then crashed by 94.33% to $23.0 million in 2021, then plummeted by 1456.52% to -$312.0 million in 2022, then surged by 307.05% to $646.0 million in 2023, then soared by 48.45% to $959.0 million in 2024.
- Its EBITDA stands at $959.0 million for Q4 2024, versus $1.0 billion for Q3 2024 and $1.0 billion for Q2 2024.